Nutresa 1Q2018 results preview

stocks and shares

Under a dynamic that continues to recover in Colombia combined with the strengthening of international sales, the issuer achieved a significant increase in registered sales compared to the same period in 2017, of which management oriented towards productivity and efficiency in expenses, as well as investment in the market continue to be the mainSee more

Subscribe

Receive our analysis in your email to stay up to date. Stay connected with the economic situation and the market.

Posts

Inflation and exchange rate: Inflation surprises and resumes upward pressure: How does the TRM interpret it?

For the foreign exchange market, the surprise in the March data and the expectation of a more restrictive monetary policy for a longer period have strengthened one of the currency's main structural supports: the carry channel. This feature continues to give the Colombian peso significant appeal, particularly in an environment where the global dollar has lost some momentum, but the selection process within Latin America has become more demanding.

Shareholders' meetings

Find an executive summary of the most relevant aspects discussed at the 2026 Annual General Meetings. This report focuses on the business management milestones during the year, the ESG progress reported in the supporting material, and the final approval of statutory reforms, profit distribution (dividend) projects, and share buyback program authorizations by the General Meetings.

Equity Report: Summary of Corporate Results for 2025

The financial results for Q4 2025 and the full year 2025 were impacted by corporate events such as the consolidation of Davivienda Group, the sale of Multibank by Grupo Aval, and the divestment of Banistmo by Grupo Cibest. Furthermore, while economic growth showed resilience, the monetary and regulatory environment remained challenging. In the fourth quarter of 25, we rated the reports of 5 issuers as having “positive results” (31%), 7 as having “neutral results” (44%), and 4 as having “negative results” (25%).